Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (3) 3
1st-line treatment (2) 2
care and treatment (2) 2
diagnosis (2) 2
index medicus (2) 2
journal article (2) 2
lymphomas (2) 2
response criteria (2) 2
stem cells (2) 2
transplantation (2) 2
usage (2) 2
acute kidney injury - chemically induced (1) 1
anemia - chemically induced (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antiretroviral agents (1) 1
antiretroviral therapy (1) 1
autografts (1) 1
b-cell lymphoma (1) 1
blood (1) 1
burkitt's lymphoma (1) 1
cancer (1) 1
cd4 antigen (1) 1
cells (1) 1
central nervous system neoplasms - diagnostic imaging (1) 1
central nervous system neoplasms - mortality (1) 1
central nervous system neoplasms - therapy (1) 1
central-nervous-system (1) 1
chemical and drug induced liver injury - epidemiology (1) 1
chemotherapy (1) 1
clinical-practice guidelines (1) 1
cognitive functions (1) 1
combined modality therapy - adverse effects (1) 1
combined modality therapy - methods (1) 1
comparative effectiveness research (1) 1
complications and side effects (1) 1
cytarabine (1) 1
cytarabine - adverse effects (1) 1
cytarabine - therapeutic use (1) 1
death, sudden - epidemiology (1) 1
denmark (1) 1
dexamethasone - therapeutic use (1) 1
disease-free survival (1) 1
dosage and administration (1) 1
equipment and supplies (1) 1
female (1) 1
follow-up (1) 1
follow-up studies (1) 1
gastrointestinal diseases - chemically induced (1) 1
germany (1) 1
guidelines (1) 1
heart injuries - chemically induced (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation - adverse effects (1) 1
hematopoietic stem cell transplantation - methods (1) 1
hematopoietic stem cells (1) 1
hemopoiesis (1) 1
high-dose chemotherapy (1) 1
high-dose therapy (1) 1
hiv patients (1) 1
hodgkin's disease (1) 1
human immunodeficiency virus--hiv (1) 1
humans (1) 1
hyperglycemia - chemically induced (1) 1
immunodeficiency (1) 1
immunology (1) 1
induction chemotherapy - adverse effects (1) 1
induction chemotherapy - methods (1) 1
infection - chemically induced (1) 1
intraocular lymphoma - diagnostic imaging (1) 1
intraocular lymphoma - therapy (1) 1
italy (1) 1
kaplan-meier estimate (1) 1
life (1) 1
lymphocytes b (1) 1
lymphoma (1) 1
lymphoma, b-cell - diagnostic imaging (1) 1
lymphoma, b-cell - mortality (1) 1
lymphoma, b-cell - therapy (1) 1
magnetic resonance imaging (1) 1
male (1) 1
methotrexate (1) 1
methotrexate - adverse effects (1) 1
methotrexate - therapeutic use (1) 1
middle aged (1) 1
mucositis - chemically induced (1) 1
multicenter (1) 1
multivariate analysis (1) 1
nervous-system lymphoma (1) 1
neurotoxicity syndromes - epidemiology (1) 1
neutropenia - chemically induced (1) 1
non-hodgkin-lymphoma (1) 1
non-hodgkins-lymphoma (1) 1
oncology (1) 1
optic nerve neoplasms - diagnostic imaging (1) 1
optic nerve neoplasms - therapy (1) 1
patient outcomes (1) 1
plasmablastic lymphoma (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
by Ferreri, Andrés J M, Dr and Cwynarski, Kate, MD and Pulczynski, Elisa, MD and Ponzoni, Maurilio, Prof and Deckert, Martina, Prof and Politi, Letterio S, MD and Torri, Valter, MD and Fox, Christopher P, MD and Rosée, Paul La, MD and Schorb, Elisabeth, MD and Ambrosetti, Achille, Prof and Roth, Alexander, MD and Hemmaway, Claire, MD and Ferrari, Angela, MD and Linton, Kim M, PhD and Rudà, Roberta, MD and Binder, Mascha, Prof and Pukrop, Tobias, Prof and Balzarotti, Monica, MD and Fabbri, Alberto, MD and Johnson, Peter, Prof and Gørløv, Jette Sønderskov, PhD and Hess, Georg, MD and Panse, Jens, MD and Pisani, Francesco, MD and Tucci, Alessandra, MD and Stilgenbauer, Stephan, Prof and Hertenstein, Bernd, MD and Keller, Ulrich, Prof and Krause, Stefan W, Prof and Levis, Alessandro, MD and Schmoll, Hans J, MD and Cavalli, Franco, Prof and Finke, Jürgen, Prof and Reni, Michele, MD and Zucca, Emanuele, MD and Illerhaus, Gerald, Prof and IELSG and International Extranodal Lymphoma Study Group (IELSG)
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party
by Hübel, Kai and Re, Alessandro and Boumendil, Ariane and Finel, Herve and Hentrich, Marcus and Robinson, Stephen and Wyen, Christoph and Michieli, Mariagrazia and Kanfer, Edward and Diez-Martin, Jose Luis and Balsalobre, Pascual and Vincent, Laure and Schroyens, Wilfried and Santasusana, Josep Maria Ribera and Kröger, Nicolaus and Schiel, Xaver and Cwynarski, Kate and Esquirol, Albert and Sousa, Aida Botelho and Cattaneo, Chiara and Montoto, Silvia and Dreger, Peter
Bone Marrow Transplantation, ISSN 0268-3369, 2019, Volume 54, Issue 10, pp. 1625 - 1631
The present study aimed at describing the outcome of patients with HIV-associated lymphomas following autologous hematopoietic stem cell transplantation... 
SURVIVAL | DIAGNOSIS | RISK | IMMUNOLOGY | TRANSPLANTATION | CLINICAL-PRACTICE GUIDELINES | ONCOLOGY | PLASMABLASTIC LYMPHOMA | HIGH-DOSE THERAPY | NON-HODGKIN-LYMPHOMA | HEMATOLOGY | IMMUNODEFICIENCY | BLOOD | Antimitotic agents | Care and treatment | Usage | Patient outcomes | HIV patients | Lymphomas | Transplantation | Equipment and supplies | Antineoplastic agents | Hematopoietic stem cells | Autografts | Stem cell transplantation | Rituximab | Multivariate analysis | Risk analysis | Survival | Lymphoma | Antiretroviral therapy | Risk factors | CD4 antigen | Hemopoiesis | Burkitt's lymphoma | Lymphocytes B | Antiretroviral agents | Human immunodeficiency virus--HIV | Stem cells | Remission | Hodgkin's disease | B-cell lymphoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
by Ferreri, Andrés J M and Cwynarski, Kate and Pulczynski, Elisa and Fox, Christopher P and Schorb, Elisabeth and La Rosée, Paul and Binder, Mascha and Fabbri, Alberto and Torri, Valter and Minacapelli, Eleonora and Falautano, Monica and Ilariucci, Fiorella and Ambrosetti, Achille and Roth, Alexander and Hemmaway, Claire and Johnson, Peter and Linton, Kim M and Pukrop, Tobias and Sønderskov Gørløv, Jette and Balzarotti, Monica and Hess, Georg and Keller, Ulrich and Stilgenbauer, Stephan and Panse, Jens and Tucci, Alessandra and Orsucci, Lorella and Pisani, Francesco and Levis, Alessandro and Krause, Stefan W and Schmoll, Hans J and Hertenstein, Bernd and Rummel, Mathias and Smith, Jeffery and Pfreundschuh, Michael and Cabras, Giuseppina and Angrilli, Francesco and Ponzoni, Maurilio and Deckert, Martina and Politi, Letterio S and Finke, Jürgen and Reni, Michele and Cavalli, Franco and Zucca, Emanuele and Illerhaus, Gerald and IELSG
The Lancet Haematology, ISSN 2352-3026, 11/2017, Volume 4, Issue 11, pp. e510 - e523
The International Extranodal Lymphoma Study Group-32 (IELSG32) trial is an international randomised phase 2 study that addresses two key clinical questions in... 
COGNITIVE FUNCTIONS | 1ST-LINE TREATMENT | MULTICENTER | SINGLE | RESPONSE CRITERIA | CYTARABINE | HEMATOLOGY | NERVOUS-SYSTEM LYMPHOMA | CHEMOTHERAPY | LIFE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.